FDA Inspection 1312406 — Vipamat SAS
The FDA completed an inspection of Vipamat SAS on March 18, 2026 in Ploemeur. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Ploemeur (France)